Company Valuation: Abbott Laboratories

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 241,365 191,427 191,088 196,184 217,859 154,150 - -
Change - -20.69% -0.18% 2.67% 11.05% -29.24% - -
Enterprise Value (EV) 1 249,166 198,318 198,871 202,693 222,266 165,877 163,033 159,127
Change - -20.41% 0.28% 1.92% 9.66% -25.37% -1.71% -2.4%
P/E 35.7x 28.1x 33.8x 14.8x 33.7x 22.3x 19.1x 16.7x
PBR 6.93x 5.2x 4.94x 4.11x 4.18x 3.12x 2.99x 2.79x
PEG - -36.9x -2x 0x -0.7x 3.24x 1.2x 1.2x
Capitalization / Revenue 5.6x 4.39x 4.76x 4.68x 4.91x 3.07x 2.81x 2.63x
EV / Revenue 5.78x 4.54x 4.96x 4.83x 5.01x 3.3x 2.98x 2.71x
EV / EBITDA 19.4x 15.9x 19.5x 19.1x 18.9x 12.4x 11.2x 9.99x
EV / EBIT 22x 17.7x 22.3x 21.8x 21.6x 14.2x 12.5x 11.1x
EV / FCF 28.8x 25.4x 39.3x 31.9x 30.1x 19.2x 17.3x 15.3x
FCF Yield 3.47% 3.94% 2.54% 3.13% 3.33% 5.2% 5.79% 6.53%
Dividend per Share 2 1.82 1.92 2.08 2.24 2.4 2.547 2.715 2.866
Rate of return 1.29% 1.75% 1.89% 1.98% 1.92% 2.88% 3.07% 3.24%
EPS 2 3.94 3.91 3.26 7.64 3.72 3.976 4.636 5.291
Distribution rate 46.2% 49.1% 63.8% 29.3% 64.5% 64% 58.6% 54.2%
Net sales 1 43,075 43,653 40,109 41,950 44,328 50,290 54,793 58,704
EBITDA 1 12,815 12,485 10,188 10,635 11,735 13,388 14,551 15,928
EBIT 1 11,324 11,231 8,911 9,295 10,301 11,665 13,038 14,362
Net income 1 7,071 6,933 5,723 13,402 6,524 7,019 8,392 9,230
Net Debt 1 7,801 6,891 7,783 6,509 4,407 11,727 8,883 4,976
Reference price 2 140.74 109.79 110.07 113.11 125.29 88.50 88.50 88.50
Nbr of stocks (in thousands) 1,714,968 1,743,574 1,736,059 1,734,455 1,738,834 1,741,813 - -
Announcement Date 1/26/22 1/25/23 1/24/24 1/22/25 1/22/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
20.44x3.52x12.66x3.52% 104B
34.24x8.33x21.84x1.17% 56.43B
14.83x0.18x11.12x0.84% 54.76B
36.17x2.91x10x2.65% 40B
35.51x1.31x11.57x0.22% 31.36B
29.89x5.33x16.99x-.--% 28.23B
39.14x6.77x24.42x0.27% 23.28B
23.94x3.05x12.47x1.35% 20.41B
22.91x3.3x11.87x1.28% 20.13B
Average 28.56x 3.86x 14.77x 1.26% 42.11B
Weighted average by Cap. 26.76x 3.80x 14.43x 1.72%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. ABT Stock
  5. Valuation Abbott Laboratories
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!